List of Schedule V drugs

List of Schedule V Drugs refers to a classification of controlled substances in many countries, particularly in the United States under the Controlled Substances Act (CSA). Schedule V drugs are considered to have a lower potential for abuse compared to the substances listed in Schedules I through IV and are often used for antitussive, antidiarrheal, and analgesic purposes. This category includes a variety of medications that, while controlled, are deemed to have legitimate medical uses and a lower risk of dependency.

Classification and Examples[edit | edit source]

Schedule V drugs are characterized by their lower potential for abuse and dependence compared to higher schedule drugs. They often contain limited quantities of certain narcotics. Examples of substances classified under Schedule V include:

Cough preparations containing less than 200 milligrams of codeine per 100 milliliters or per 100 grams (e.g., Robitussin AC, Phenergan with Codeine)
Antidiarrheals containing diphenoxylate (less than 2.5 milligrams) and atropine (less than 25 micrograms) (e.g., Lomotil)
Pregabalin (Lyrica)
Ezogabine (Potiga)

Legal Status[edit | edit source]

In the United States, the Drug Enforcement Administration (DEA) regulates the distribution, use, and manufacturing of Schedule V drugs. While these drugs are considered to have a lower risk of abuse, they are still controlled, meaning they require a prescription for use and are subject to manufacturing quotas and record-keeping requirements.

Medical Use[edit | edit source]

Schedule V drugs are used in a variety of medical settings, primarily for their antitussive, antidiarrheal, and analgesic properties. For example, cough preparations containing codeine are used to suppress severe coughing, while antidiarrheals like Lomotil are prescribed for the treatment of diarrhea.

Abuse and Dependence[edit | edit source]

Although Schedule V drugs are deemed to have a lower potential for abuse, there is still a risk of dependence and misuse. Abuse of these substances can lead to physical and psychological dependence, particularly with prolonged use or in higher doses than prescribed.

Regulatory Considerations[edit | edit source]

Healthcare providers prescribing Schedule V drugs must adhere to federal and state regulations, including verifying the necessity of the drug for the patient, prescribing the lowest effective dose, and monitoring for signs of abuse and dependence.